Cargando…
Mechanistic insights into the efficacy of cell penetrating peptide-based cancer vaccines
Immunotherapies are increasingly used to treat cancer, with some outstanding results. Immunotherapy modalities include therapeutic vaccination to eliminate cancer cells through the activation of patient’s immune system against tumor-derived antigens. Nevertheless, the full potential of therapeutic v...
Autores principales: | Grau, Morgan, Walker, Paul R., Derouazi, Madiha |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer International Publishing
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6061156/ https://www.ncbi.nlm.nih.gov/pubmed/29508006 http://dx.doi.org/10.1007/s00018-018-2785-0 |
Ejemplares similares
-
Cell-penetrating peptides—the Swiss Army knife of cancer vaccines
por: Walker, Paul R., et al.
Publicado: (2015) -
Heterologous Prime-Boost Vaccination with a Peptide-Based Vaccine and Viral Vector Reshapes Dendritic Cell, CD4+ and CD8+ T Cell Phenotypes to Improve the Antitumor Therapeutic Effect
por: Hofer, Tamara, et al.
Publicado: (2021) -
Mechanistic studies of intracellular delivery of proteins by cell-penetrating peptides in cyanobacteria
por: Liu, Betty R, et al.
Publicado: (2013) -
STING Agonist Combined to a Protein-Based Cancer Vaccine Potentiates Peripheral and Intra-Tumoral T Cell Immunity
por: Rossi, Matteo, et al.
Publicado: (2021) -
Use of Cell-Penetrating Peptides in Dendritic Cell-Based Vaccination
por: Lim, Sangho, et al.
Publicado: (2016)